BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12631132)

  • 1. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis.
    Asplin JR; Bauer KA; Kinder J; Müller G; Coe BJ; Parks JH; Coe FL
    Kidney Int; 2003 Feb; 63(2):662-9. PubMed ID: 12631132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine calcium excretion predicts bone loss in idiopathic hypercalciuria.
    Asplin JR; Donahue S; Kinder J; Coe FL
    Kidney Int; 2006 Oct; 70(8):1463-7. PubMed ID: 16941029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis.
    Sakhaee K; Maalouf NM; Poindexter J; Adams-Huet B; Moe OW
    J Urol; 2017 Jun; 197(6):1472-1477. PubMed ID: 28063842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTH and 1.25 vitamin D response to a low-calcium diet is associated with bone mineral density in renal stone formers.
    Pasch A; Frey FJ; Eisenberger U; Mohaupt MG; Bonny O
    Nephrol Dial Transplant; 2008 Aug; 23(8):2563-70. PubMed ID: 18398019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sodium chloride intake is associated with low bone density in calcium stone-forming patients.
    Martini LA; Cuppari L; Colugnati FA; Sigulem DM; Szejnfeld VL; Schor N; Heilberg IP
    Clin Nephrol; 2000 Aug; 54(2):85-93. PubMed ID: 10968683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results].
    Moyano MJ; Gómez de Tejada MJ; García Lozano R; Moruno R; Ortega R; Martí V; Sánchez Palencia R; Miranda MJ; Palma A; Pérez Cano R
    Nefrologia; 2007; 27(6):694-703. PubMed ID: 18336098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study of dietary calcium and other nutrients in idiopathic renal calcium stone formers with low bone mineral content.
    Trinchieri A; Nespoli R; Ostini F; Rovera F; Zanetti G; Pisani E
    J Urol; 1998 Mar; 159(3):654-7. PubMed ID: 9474119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low bone mineral density and peripheral blood monocyte activation profile in calcium stone formers with idiopathic hypercalciuria.
    Ghazali A; Fuentès V; Desaint C; Bataille P; Westeel A; Brazier M; Prin L; Fournier A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):32-8. PubMed ID: 8989228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor gene polymorphism and bone mineral density in hypercalciuric calcium-stone-forming patients.
    Heilberg IP; Teixeira SH; Martini LA; Boim MA
    Nephron; 2002 Jan; 90(1):51-7. PubMed ID: 11744805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diet, vitamin D and vertebral mineral density in hypercalciuric calcium stone formers.
    Bataille P; Achard JM; Fournier A; Boudailliez B; Westeel PF; el Esper N; Bergot C; Jans I; Lalau JD; Petit J
    Kidney Int; 1991 Jun; 39(6):1193-205. PubMed ID: 1895673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low bone mass in idiopathic renal stone formers: magnitude and significance.
    Jaeger P; Lippuner K; Casez JP; Hess B; Ackermann D; Hug C
    J Bone Miner Res; 1994 Oct; 9(10):1525-32. PubMed ID: 7817797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between bone and stone formation.
    Krieger NS; Bushinsky DA
    Calcif Tissue Int; 2013 Oct; 93(4):374-81. PubMed ID: 23247537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal Calcium Absorption among Hypercalciuric Patients with or without Calcium Kidney Stones.
    Vezzoli G; Macrina L; Rubinacci A; Spotti D; Arcidiacono T
    Clin J Am Soc Nephrol; 2016 Aug; 11(8):1450-1455. PubMed ID: 27284011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats.
    Bushinsky DA; Neumann KJ; Asplin J; Krieger NS
    Kidney Int; 1999 Jan; 55(1):234-43. PubMed ID: 9893132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular calcification and bone mineral density in recurrent kidney stone formers.
    Shavit L; Girfoglio D; Vijay V; Goldsmith D; Ferraro PM; Moochhala SH; Unwin R
    Clin J Am Soc Nephrol; 2015 Feb; 10(2):278-85. PubMed ID: 25635036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-Based Diagnosis of Low Vertebral Bone Mineral Density Is Associated with Hypercalciuria and Hypocitraturia on Opportunistic Imaging.
    Patel ND; Ward RD; Calle J; Remer EM; Monga M
    J Endourol; 2018 Sep; 32(9):878-883. PubMed ID: 29954225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria.
    Vezzoli G; Rubinacci A; Bianchin C; Arcidiacono T; Giambona S; Mignogna G; Fochesato E; Terranegra A; Cusi D; Soldati L
    Am J Kidney Dis; 2003 Dec; 42(6):1177-83. PubMed ID: 14655189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bone mineral density status of patients with kidney stones stratified by stone composition.
    Cong X; Huang L; Wang X; Li L; Zhang X; Chen X; Xu Y
    World J Urol; 2024 Jan; 42(1):42. PubMed ID: 38244092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral calcium loading on intact PTH and calcitriol in idiopathic renal calcium stone formers and healthy controls.
    Hess B; Lippuner K; Takkinen R; Villiger L; Ackermann D; Jaeger P
    Nephrol Dial Transplant; 1995; 10(9):1614-9. PubMed ID: 8559479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors.
    Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S
    J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.